Table II.
Baseline clinical characteristics of the study subjects.
| Test supplement dose | |||
|---|---|---|---|
| Variables | Placebo (n=15) | Low (n=16) | High (n=16) |
| Age, years | 44.2±1.8 | 45.0±1.9 | 43.8±2.1 |
| Body weight, kg | 74.1±2.7 | 74.8±2.0 | 74.9±3.1 |
| Body mass index, kg/m2 | 24.7±0.7 | 25.5±0.7 | 25.7±0.7 |
| Systolic blood pressure, mmHg | 125.6±4.0 | 124.3±3.8 | 125.7±2.5 |
| Diastolic blood pressure, mmHg | 79.5±2.6 | 83.0±3.0 | 77.9±2.0 |
| Pulse rate, beats min−1 | 71.1±1.6 | 70.1±1.4 | 72.7±2.0 |
| Serum uric acid, mg/dl | 7.1±0.1 | 7.2±0.1 | 7.2±0.1 |
Values are expressed as the mean ± standard error.